ClinicalTrials.Veeva

Menu

Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity

A

Ain Shams University

Status

Completed

Conditions

HBP
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT05610020
FMASU M D 159/ 2021

Details and patient eligibility

About

the aim of the study is to correlate between the severity of sepsis and serum heparin binding protein in the patients admitted to ICU with sepsis., and detect its value as a prognostic biomarker in sepsis

Enrollment

55 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult whose age between 20 to70 years old
  • patients suffered from sepsis or septic shock (under the third international consensus definition of sepsis and septic shock)

Exclusion criteria

  • Any pregnancy female
  • Any patient who is Neutropenic secondary to malignancy
  • Patients who is taking immunosuppressive therapy
  • Patients who is suffering fromHematological malignancy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems